首页> 外国专利> COMPOSITION FOR PREDICTING RISK OF THIOPURINE-INDUCED LEUKOPENIA, CONTAINING SINGLE NUCLEOTIDE POLYMORPHISM MARKER WITHIN NUDT15 GENE

COMPOSITION FOR PREDICTING RISK OF THIOPURINE-INDUCED LEUKOPENIA, CONTAINING SINGLE NUCLEOTIDE POLYMORPHISM MARKER WITHIN NUDT15 GENE

机译:预测硫代嘌呤诱发的白细胞减少症风险的组合物,其中含有NUDT15基因中的单个核苷酸多态性标记

摘要

The present invention relates to a composition for predicting the risk of thiopurine-induced leukopenia, containing a single nucleotide polymorphism marker within NUDT15 gene, and specifically, to: a composition for predicting the risk of thiopurine-induced leukopenia in Crohn's disease, ulcerative colitis, leukemia or transplant patients, containing a single nucleotide polymorphism marker within NUDT15 gene; a kit for predicting the risk; and a method for predicting the risk. According to the present invention, a patient having high sensitivity to leukopenia, which occurs during thiopurine therapy, in Crohn's disease, ulcerative colitis, leukemia or transplant patients can be rapidly classified early on, and thus patient-customized therapy can be efficiently carried out.
机译:本发明涉及用于预测硫嘌呤诱导的白细胞减少症风险的组合物,其在NUDT15基因内包含单核苷酸多态性标记物,并且具体地,涉及:用于预测在克罗恩病,溃疡性结肠炎,白血病或移植患者,在NUDT15基因内含有单核苷酸多态性标记;预测风险的工具包;以及预测风险的方法。根据本发明,对于硫代嘌呤治疗期间发生的白细胞减少症具有高敏感性的患者,在克罗恩氏病,溃疡性结肠炎,白血病或移植患者中,可以及早地被分类,因此可以有效地进行患者定制的治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号